Trial intelligence / Profile preview

Isoproterenol for Intrarenal Pressure During Ureterorenoscopy

NCT00428428Phase 3Completed

Sponsor
Fredericia Hospital
Start
Feb 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised trial of isoprenaline in nephrolithiasis and hematuria, sponsored by Fredericia Hospital. Primary endpoint: Intrarenal pelvic pressure. Started Feb 2007; status: completed.

02

Drugs

isoprenaline
03

Conditions

nephrolithiasishematuria

Beyond the preview

Go deeper on NCT00428428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00428428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call